NCT05565417 2025-10-16
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
Immunitas Therapeutics
Phase 1/2 Active not recruiting
Immunitas Therapeutics
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School